Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes ...

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing another antimony project acquisition from Trigg ...

EBR Systems (ASX:EBR) announces the US FDA has accepted its final premarket approval application for the WiSE CRT System.

Magnetic Resources receives firm commitments from professional, sophisticated and institutional investors to raise $10m at ...

Australian Rare Earths’ Koppamurra increases, Alderan eyes 28% copper at Cactus and Hazer hits graphite milestone.

Trigg Minerals (ASX:TMG) has inked a deal to acquire Achilles, home to the high-grade and high-tonnage Wild Cattle Creek ...

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing a new preliminary feasibility study from Lithium ...

Probiotics maker Biome seeks to almost quadruple its revenues as it evolves from microcap to significant entrant in the ...

Dr Michael Thurn joins Sarah Hughan on Stockhead TV to talk about its treatment for amyotrophic lateral sclerosis.

Clinical-stage stem cell and regenerative medicine firm Cynata has four trials underway, three ending between late this year ...

ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.

Raiden (ASX:RDN) has deepened its understanding of Andover South after completing a preliminary structural analysis of its ...